Cytokinetics
CYTK
CYTK
158 hedge funds and large institutions have $1.36B invested in Cytokinetics in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 147 → 158 (+11)
3.62% more ownership
Funds ownership: 93.75% → 97.37% (+3.6%)
33% less call options, than puts
Call options by funds: $5.33M | Put options by funds: $7.93M
Holders
158
Holding in Top 10
7
Calls
$5.33M
Puts
$7.93M
Top Buyers
| 1 | +$71M | |
| 2 | +$20.6M | |
| 3 | +$20.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$14.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.6M |
Top Sellers
| 1 | -$46.4M | |
| 2 | -$13.4M | |
| 3 | -$11.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.9M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$10.6M |